ROS1+ cancer is incredible rare. Most physicians will never meet a patient who has it, and few clinics see enough patients to generate useful research and clinical care data. But it is research that saves lives.
The ROS1ders believe collecting diagnosis, treatment, outcome and patient experience information from an international group of patients over time is our best option for identifying optimal care.
Cindy, a ROS1der, shares what research means to her.
Please help us to improve outcomes for all ROS1+ cancers by donating to The ROS1ders for the Global ROS1 Initiative.
Comments